Hotline: +86-18022463983    020-85206863

Global Generative Biology Intelligent Manufacturing Platform Market Research Report 2026

Published Date: 2026-03-12   |   Pages: 113   |   Tables: 111   |  Service & Software

The global Generative Biology Intelligent Manufacturing Platform market was valued at US$ 5012 million in 2025 and is anticipated to reach US$ 11137 million by 2032, at a CAGR of 12.1% from 2026 to 2032.
The Generative Biology Intelligent Manufacturing Platform is a comprehensive platform that uses synthetic biology and generative design technologies, combined with automation, high-throughput screening and artificial intelligence, to design, create and optimize biological systems and biological products. Through this platform, a variety of products such as drugs, chemicals, materials, food ingredients and energy can be efficiently developed and produced, achieving innovation and sustainable development in various industries.
The industrial chain of the generative biology intelligent manufacturing platform can be divided into three major segments: upstream "biological and digital foundation", midstream "platform-based intelligent manufacturing capabilities", and downstream "application and commercialization". The upstream includes gene sequencing/synthesis, cell lines and chassis biology, reagents and consumables, automated experimental equipment, as well as computing infrastructure and AI algorithm tools, providing data, biomaterials and computing power for the platform. The midstream is the core generative biology intelligent manufacturing platform, which integrates generative AI models, digital twin biological systems, automated DBTL (design-build-test-learn) closed loop and cloud-based laboratories to achieve rapid design and optimization of molecules, strains and biological processes. It is the segment with the highest technical barriers and added value in the industrial chain. The downstream targets application scenarios such as pharmaceutical R&D and CDMO, bio-based materials, industrial enzymes and synthetic biochemicals, agricultural biotechnology and food and flavorings, and realizes monetization through technology licensing, joint development, product revenue sharing or large-scale production. In terms of gross profit margin, upstream reagents, consumables and equipment typically have a margin of 30%–55%, while computing power and software tools have a margin of about 60%–80%. Midstream generative biological intelligent manufacturing platforms, which are centered on software, algorithms and data, generally have a gross profit margin of 65%–85%. Downstream applications vary greatly due to differences in product attributes, with pharmaceuticals and high-end biomaterials reaching 60%–75%, while bulk biochemicals and enzyme preparations are mostly in the range of 30%–50%.
The Generative Biology Intelligent Manufacturing Platform integrates synthetic biology, generative design and artificial intelligence, and represents the cutting-edge technology of biomanufacturing. Through efficient design, optimization and production processes, it significantly accelerates the development and marketization of new products. This platform has shown great potential in the fields of medicine, agriculture, biomaterials, etc., promoting industrial innovation, promoting the sustainable use of resources, and providing new solutions to solve the environmental and resource challenges facing the world.
This report delivers a comprehensive overview of the global Generative Biology Intelligent Manufacturing Platform market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Generative Biology Intelligent Manufacturing Platform. The Generative Biology Intelligent Manufacturing Platform market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Generative Biology Intelligent Manufacturing Platform market comprehensively. Regional market sizes by Type, by Application, by Closed-Loop Coverage, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Generative Biology Intelligent Manufacturing Platform manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Ginkgo Bioworks
Absci
Amyris
Genomatica
Twist Bioscience
Inscripta
Synthego
Arzeda
Benchling
Insilico Medicine
Generate Biomedicines
Recursion Pharmaceuticals
Deep Genomics
Segment by Type
Cloud-Based
On-Premises
Segment by Closed-Loop Coverage
Single-Stage Platform
Multi-Stage Platform
Full-Process Closed-Loop Platform
Segment by Biological Objects
Molecular-Level Platform
Cellular-Level Platform
Segment by Application
Medical Industry
Agriculture
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Closed-Loop Coverage, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Generative Biology Intelligent Manufacturing Platform companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generative Biology Intelligent Manufacturing Platform Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Cloud-Based
1.2.3 On-Premises
1.3 Market by Closed-Loop Coverage
1.3.1 Global Generative Biology Intelligent Manufacturing Platform Market Size Growth Rate by Closed-Loop Coverage: 2021 vs 2025 vs 2032
1.3.2 Single-Stage Platform
1.3.3 Multi-Stage Platform
1.3.4 Full-Process Closed-Loop Platform
1.4 Market by Biological Objects
1.4.1 Global Generative Biology Intelligent Manufacturing Platform Market Size Growth Rate by Biological Objects: 2021 vs 2025 vs 2032
1.4.2 Molecular-Level Platform
1.4.3 Cellular-Level Platform
1.5 Market by Application
1.5.1 Global Generative Biology Intelligent Manufacturing Platform Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Medical Industry
1.5.3 Agriculture
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Generative Biology Intelligent Manufacturing Platform Market Perspective (2021–2032)
2.2 Global Generative Biology Intelligent Manufacturing Platform Growth Trends by Region
2.2.1 Global Generative Biology Intelligent Manufacturing Platform Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Generative Biology Intelligent Manufacturing Platform Historic Market Size by Region (2021–2026)
2.2.3 Generative Biology Intelligent Manufacturing Platform Forecasted Market Size by Region (2027–2032)
2.3 Generative Biology Intelligent Manufacturing Platform Market Dynamics
2.3.1 Generative Biology Intelligent Manufacturing Platform Industry Trends
2.3.2 Generative Biology Intelligent Manufacturing Platform Market Drivers
2.3.3 Generative Biology Intelligent Manufacturing Platform Market Challenges
2.3.4 Generative Biology Intelligent Manufacturing Platform Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generative Biology Intelligent Manufacturing Platform Players by Revenue
3.1.1 Global Top Generative Biology Intelligent Manufacturing Platform Players by Revenue (2021–2026)
3.1.2 Global Generative Biology Intelligent Manufacturing Platform Revenue Market Share by Players (2021–2026)
3.2 Global Top Generative Biology Intelligent Manufacturing Platform Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Generative Biology Intelligent Manufacturing Platform Revenue
3.4 Global Generative Biology Intelligent Manufacturing Platform Market Concentration Ratio
3.4.1 Global Generative Biology Intelligent Manufacturing Platform Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generative Biology Intelligent Manufacturing Platform Revenue in 2025
3.5 Global Key Players of Generative Biology Intelligent Manufacturing Platform Head Offices and Areas Served
3.6 Global Key Players of Generative Biology Intelligent Manufacturing Platform, Products and Applications
3.7 Global Key Players of Generative Biology Intelligent Manufacturing Platform, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Generative Biology Intelligent Manufacturing Platform Breakdown Data by Type
4.1 Global Generative Biology Intelligent Manufacturing Platform Historic Market Size by Type (2021–2026)
4.2 Global Generative Biology Intelligent Manufacturing Platform Forecasted Market Size by Type (2027–2032)
5 Generative Biology Intelligent Manufacturing Platform Breakdown Data by Application
5.1 Global Generative Biology Intelligent Manufacturing Platform Historic Market Size by Application (2021–2026)
5.2 Global Generative Biology Intelligent Manufacturing Platform Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Generative Biology Intelligent Manufacturing Platform Market Size (2021–2032)
6.2 North America Generative Biology Intelligent Manufacturing Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Generative Biology Intelligent Manufacturing Platform Market Size by Country (2021–2026)
6.4 North America Generative Biology Intelligent Manufacturing Platform Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Generative Biology Intelligent Manufacturing Platform Market Size (2021–2032)
7.2 Europe Generative Biology Intelligent Manufacturing Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Generative Biology Intelligent Manufacturing Platform Market Size by Country (2021–2026)
7.4 Europe Generative Biology Intelligent Manufacturing Platform Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Generative Biology Intelligent Manufacturing Platform Market Size (2021–2032)
8.2 Asia-Pacific Generative Biology Intelligent Manufacturing Platform Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Generative Biology Intelligent Manufacturing Platform Market Size by Region (2021–2026)
8.4 Asia-Pacific Generative Biology Intelligent Manufacturing Platform Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Generative Biology Intelligent Manufacturing Platform Market Size (2021–2032)
9.2 Latin America Generative Biology Intelligent Manufacturing Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Generative Biology Intelligent Manufacturing Platform Market Size by Country (2021–2026)
9.4 Latin America Generative Biology Intelligent Manufacturing Platform Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generative Biology Intelligent Manufacturing Platform Market Size (2021–2032)
10.2 Middle East & Africa Generative Biology Intelligent Manufacturing Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Generative Biology Intelligent Manufacturing Platform Market Size by Country (2021–2026)
10.4 Middle East & Africa Generative Biology Intelligent Manufacturing Platform Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ginkgo Bioworks
11.1.1 Ginkgo Bioworks Company Details
11.1.2 Ginkgo Bioworks Business Overview
11.1.3 Ginkgo Bioworks Generative Biology Intelligent Manufacturing Platform Introduction
11.1.4 Ginkgo Bioworks Revenue in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
11.1.5 Ginkgo Bioworks Recent Development
11.2 Absci
11.2.1 Absci Company Details
11.2.2 Absci Business Overview
11.2.3 Absci Generative Biology Intelligent Manufacturing Platform Introduction
11.2.4 Absci Revenue in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
11.2.5 Absci Recent Development
11.3 Amyris
11.3.1 Amyris Company Details
11.3.2 Amyris Business Overview
11.3.3 Amyris Generative Biology Intelligent Manufacturing Platform Introduction
11.3.4 Amyris Revenue in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
11.3.5 Amyris Recent Development
11.4 Genomatica
11.4.1 Genomatica Company Details
11.4.2 Genomatica Business Overview
11.4.3 Genomatica Generative Biology Intelligent Manufacturing Platform Introduction
11.4.4 Genomatica Revenue in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
11.4.5 Genomatica Recent Development
11.5 Twist Bioscience
11.5.1 Twist Bioscience Company Details
11.5.2 Twist Bioscience Business Overview
11.5.3 Twist Bioscience Generative Biology Intelligent Manufacturing Platform Introduction
11.5.4 Twist Bioscience Revenue in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
11.5.5 Twist Bioscience Recent Development
11.6 Inscripta
11.6.1 Inscripta Company Details
11.6.2 Inscripta Business Overview
11.6.3 Inscripta Generative Biology Intelligent Manufacturing Platform Introduction
11.6.4 Inscripta Revenue in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
11.6.5 Inscripta Recent Development
11.7 Synthego
11.7.1 Synthego Company Details
11.7.2 Synthego Business Overview
11.7.3 Synthego Generative Biology Intelligent Manufacturing Platform Introduction
11.7.4 Synthego Revenue in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
11.7.5 Synthego Recent Development
11.8 Arzeda
11.8.1 Arzeda Company Details
11.8.2 Arzeda Business Overview
11.8.3 Arzeda Generative Biology Intelligent Manufacturing Platform Introduction
11.8.4 Arzeda Revenue in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
11.8.5 Arzeda Recent Development
11.9 Benchling
11.9.1 Benchling Company Details
11.9.2 Benchling Business Overview
11.9.3 Benchling Generative Biology Intelligent Manufacturing Platform Introduction
11.9.4 Benchling Revenue in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
11.9.5 Benchling Recent Development
11.10 Insilico Medicine
11.10.1 Insilico Medicine Company Details
11.10.2 Insilico Medicine Business Overview
11.10.3 Insilico Medicine Generative Biology Intelligent Manufacturing Platform Introduction
11.10.4 Insilico Medicine Revenue in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
11.10.5 Insilico Medicine Recent Development
11.11 Generate Biomedicines
11.11.1 Generate Biomedicines Company Details
11.11.2 Generate Biomedicines Business Overview
11.11.3 Generate Biomedicines Generative Biology Intelligent Manufacturing Platform Introduction
11.11.4 Generate Biomedicines Revenue in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
11.11.5 Generate Biomedicines Recent Development
11.12 Recursion Pharmaceuticals
11.12.1 Recursion Pharmaceuticals Company Details
11.12.2 Recursion Pharmaceuticals Business Overview
11.12.3 Recursion Pharmaceuticals Generative Biology Intelligent Manufacturing Platform Introduction
11.12.4 Recursion Pharmaceuticals Revenue in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
11.12.5 Recursion Pharmaceuticals Recent Development
11.13 Deep Genomics
11.13.1 Deep Genomics Company Details
11.13.2 Deep Genomics Business Overview
11.13.3 Deep Genomics Generative Biology Intelligent Manufacturing Platform Introduction
11.13.4 Deep Genomics Revenue in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
11.13.5 Deep Genomics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Generative Biology Intelligent Manufacturing Platform Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Cloud-Based
Table 3. Key Players of On-Premises
Table 4. Global Generative Biology Intelligent Manufacturing Platform Market Size Growth Rate by Closed-Loop Coverage (US$ Million): 2021 vs 2025 vs 2032
Table 5. Key Players of Single-Stage Platform
Table 6. Key Players of Multi-Stage Platform
Table 7. Key Players of Full-Process Closed-Loop Platform
Table 8. Global Generative Biology Intelligent Manufacturing Platform Market Size Growth Rate by Biological Objects (US$ Million): 2021 vs 2025 vs 2032
Table 9. Key Players of Molecular-Level Platform
Table 10. Key Players of Cellular-Level Platform
Table 11. Global Generative Biology Intelligent Manufacturing Platform Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 12. Global Generative Biology Intelligent Manufacturing Platform Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 13. Global Generative Biology Intelligent Manufacturing Platform Market Size by Region (US$ Million), 2021–2026
Table 14. Global Generative Biology Intelligent Manufacturing Platform Market Share by Region (2021–2026)
Table 15. Global Generative Biology Intelligent Manufacturing Platform Forecasted Market Size by Region (US$ Million), 2027–2032
Table 16. Global Generative Biology Intelligent Manufacturing Platform Market Share by Region (2027–2032)
Table 17. Generative Biology Intelligent Manufacturing Platform Market Trends
Table 18. Generative Biology Intelligent Manufacturing Platform Market Drivers
Table 19. Generative Biology Intelligent Manufacturing Platform Market Challenges
Table 20. Generative Biology Intelligent Manufacturing Platform Market Restraints
Table 21. Global Generative Biology Intelligent Manufacturing Platform Revenue by Players (US$ Million), 2021–2026
Table 22. Global Generative Biology Intelligent Manufacturing Platform Market Share by Players (2021–2026)
Table 23. Global Top Generative Biology Intelligent Manufacturing Platform Players by Tier (Tier 1, Tier 2, and Tier 3), based on Generative Biology Intelligent Manufacturing Platform Revenue, 2025
Table 24. Ranking of Global Top Generative Biology Intelligent Manufacturing Platform Companies by Revenue (US$ Million) in 2025
Table 25. Global 5 Largest Players Market Share by Generative Biology Intelligent Manufacturing Platform Revenue (CR5 and HHI), 2021–2026
Table 26. Global Key Players of Generative Biology Intelligent Manufacturing Platform, Headquarters and Area Served
Table 27. Global Key Players of Generative Biology Intelligent Manufacturing Platform, Products and Applications
Table 28. Global Key Players of Generative Biology Intelligent Manufacturing Platform, Date of General Availability (GA)
Table 29. Mergers and Acquisitions, Expansion Plans
Table 30. Global Generative Biology Intelligent Manufacturing Platform Market Size by Type (US$ Million), 2021–2026
Table 31. Global Generative Biology Intelligent Manufacturing Platform Revenue Market Share by Type (2021–2026)
Table 32. Global Generative Biology Intelligent Manufacturing Platform Forecasted Market Size by Type (US$ Million), 2027–2032
Table 33. Global Generative Biology Intelligent Manufacturing Platform Revenue Market Share by Type (2027–2032)
Table 34. Global Generative Biology Intelligent Manufacturing Platform Market Size by Application (US$ Million), 2021–2026
Table 35. Global Generative Biology Intelligent Manufacturing Platform Revenue Market Share by Application (2021–2026)
Table 36. Global Generative Biology Intelligent Manufacturing Platform Forecasted Market Size by Application (US$ Million), 2027–2032
Table 37. Global Generative Biology Intelligent Manufacturing Platform Revenue Market Share by Application (2027–2032)
Table 38. North America Generative Biology Intelligent Manufacturing Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 39. North America Generative Biology Intelligent Manufacturing Platform Market Size by Country (US$ Million), 2021–2026
Table 40. North America Generative Biology Intelligent Manufacturing Platform Market Size by Country (US$ Million), 2027–2032
Table 41. Europe Generative Biology Intelligent Manufacturing Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 42. Europe Generative Biology Intelligent Manufacturing Platform Market Size by Country (US$ Million), 2021–2026
Table 43. Europe Generative Biology Intelligent Manufacturing Platform Market Size by Country (US$ Million), 2027–2032
Table 44. Asia-Pacific Generative Biology Intelligent Manufacturing Platform Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 45. Asia-Pacific Generative Biology Intelligent Manufacturing Platform Market Size by Region (US$ Million), 2021–2026
Table 46. Asia-Pacific Generative Biology Intelligent Manufacturing Platform Market Size by Region (US$ Million), 2027–2032
Table 47. Latin America Generative Biology Intelligent Manufacturing Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 48. Latin America Generative Biology Intelligent Manufacturing Platform Market Size by Country (US$ Million), 2021–2026
Table 49. Latin America Generative Biology Intelligent Manufacturing Platform Market Size by Country (US$ Million), 2027–2032
Table 50. Middle East & Africa Generative Biology Intelligent Manufacturing Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 51. Middle East & Africa Generative Biology Intelligent Manufacturing Platform Market Size by Country (US$ Million), 2021–2026
Table 52. Middle East & Africa Generative Biology Intelligent Manufacturing Platform Market Size by Country (US$ Million), 2027–2032
Table 53. Ginkgo Bioworks Company Details
Table 54. Ginkgo Bioworks Business Overview
Table 55. Ginkgo Bioworks Generative Biology Intelligent Manufacturing Platform Product
Table 56. Ginkgo Bioworks Revenue in Generative Biology Intelligent Manufacturing Platform Business (US$ Million), 2021–2026
Table 57. Ginkgo Bioworks Recent Development
Table 58. Absci Company Details
Table 59. Absci Business Overview
Table 60. Absci Generative Biology Intelligent Manufacturing Platform Product
Table 61. Absci Revenue in Generative Biology Intelligent Manufacturing Platform Business (US$ Million), 2021–2026
Table 62. Absci Recent Development
Table 63. Amyris Company Details
Table 64. Amyris Business Overview
Table 65. Amyris Generative Biology Intelligent Manufacturing Platform Product
Table 66. Amyris Revenue in Generative Biology Intelligent Manufacturing Platform Business (US$ Million), 2021–2026
Table 67. Amyris Recent Development
Table 68. Genomatica Company Details
Table 69. Genomatica Business Overview
Table 70. Genomatica Generative Biology Intelligent Manufacturing Platform Product
Table 71. Genomatica Revenue in Generative Biology Intelligent Manufacturing Platform Business (US$ Million), 2021–2026
Table 72. Genomatica Recent Development
Table 73. Twist Bioscience Company Details
Table 74. Twist Bioscience Business Overview
Table 75. Twist Bioscience Generative Biology Intelligent Manufacturing Platform Product
Table 76. Twist Bioscience Revenue in Generative Biology Intelligent Manufacturing Platform Business (US$ Million), 2021–2026
Table 77. Twist Bioscience Recent Development
Table 78. Inscripta Company Details
Table 79. Inscripta Business Overview
Table 80. Inscripta Generative Biology Intelligent Manufacturing Platform Product
Table 81. Inscripta Revenue in Generative Biology Intelligent Manufacturing Platform Business (US$ Million), 2021–2026
Table 82. Inscripta Recent Development
Table 83. Synthego Company Details
Table 84. Synthego Business Overview
Table 85. Synthego Generative Biology Intelligent Manufacturing Platform Product
Table 86. Synthego Revenue in Generative Biology Intelligent Manufacturing Platform Business (US$ Million), 2021–2026
Table 87. Synthego Recent Development
Table 88. Arzeda Company Details
Table 89. Arzeda Business Overview
Table 90. Arzeda Generative Biology Intelligent Manufacturing Platform Product
Table 91. Arzeda Revenue in Generative Biology Intelligent Manufacturing Platform Business (US$ Million), 2021–2026
Table 92. Arzeda Recent Development
Table 93. Benchling Company Details
Table 94. Benchling Business Overview
Table 95. Benchling Generative Biology Intelligent Manufacturing Platform Product
Table 96. Benchling Revenue in Generative Biology Intelligent Manufacturing Platform Business (US$ Million), 2021–2026
Table 97. Benchling Recent Development
Table 98. Insilico Medicine Company Details
Table 99. Insilico Medicine Business Overview
Table 100. Insilico Medicine Generative Biology Intelligent Manufacturing Platform Product
Table 101. Insilico Medicine Revenue in Generative Biology Intelligent Manufacturing Platform Business (US$ Million), 2021–2026
Table 102. Insilico Medicine Recent Development
Table 103. Generate Biomedicines Company Details
Table 104. Generate Biomedicines Business Overview
Table 105. Generate Biomedicines Generative Biology Intelligent Manufacturing Platform Product
Table 106. Generate Biomedicines Revenue in Generative Biology Intelligent Manufacturing Platform Business (US$ Million), 2021–2026
Table 107. Generate Biomedicines Recent Development
Table 108. Recursion Pharmaceuticals Company Details
Table 109. Recursion Pharmaceuticals Business Overview
Table 110. Recursion Pharmaceuticals Generative Biology Intelligent Manufacturing Platform Product
Table 111. Recursion Pharmaceuticals Revenue in Generative Biology Intelligent Manufacturing Platform Business (US$ Million), 2021–2026
Table 112. Recursion Pharmaceuticals Recent Development
Table 113. Deep Genomics Company Details
Table 114. Deep Genomics Business Overview
Table 115. Deep Genomics Generative Biology Intelligent Manufacturing Platform Product
Table 116. Deep Genomics Revenue in Generative Biology Intelligent Manufacturing Platform Business (US$ Million), 2021–2026
Table 117. Deep Genomics Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report


List of Figures
Figure 1. Generative Biology Intelligent Manufacturing Platform Picture
Figure 2. Global Generative Biology Intelligent Manufacturing Platform Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Generative Biology Intelligent Manufacturing Platform Market Share by Type: 2025 vs 2032
Figure 4. Cloud-Based Features
Figure 5. On-Premises Features
Figure 6. Global Generative Biology Intelligent Manufacturing Platform Market Size Comparison by Closed-Loop Coverage (US$ Million), 2021–2032
Figure 7. Single-Stage Platform Features
Figure 8. Multi-Stage Platform Features
Figure 9. Full-Process Closed-Loop Platform Features
Figure 10. Global Generative Biology Intelligent Manufacturing Platform Market Size Comparison by Biological Objects (US$ Million), 2021–2032
Figure 11. Molecular-Level Platform Features
Figure 12. Cellular-Level Platform Features
Figure 13. Global Generative Biology Intelligent Manufacturing Platform Market Size by Application (US$ Million), 2021–2032
Figure 14. Global Generative Biology Intelligent Manufacturing Platform Market Share by Application: 2025 vs 2032
Figure 15. Medical Industry Case Studies
Figure 16. Agriculture Case Studies
Figure 17. Others Case Studies
Figure 18. Generative Biology Intelligent Manufacturing Platform Report Years Considered
Figure 19. Global Generative Biology Intelligent Manufacturing Platform Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 20. Global Generative Biology Intelligent Manufacturing Platform Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Generative Biology Intelligent Manufacturing Platform Market Share by Region: 2025 vs 2032
Figure 22. Global Generative Biology Intelligent Manufacturing Platform Market Share by Players in 2025
Figure 23. Global Generative Biology Intelligent Manufacturing Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. The Top 10 and 5 Players Market Share by Generative Biology Intelligent Manufacturing Platform Revenue in 2025
Figure 25. North America Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. North America Generative Biology Intelligent Manufacturing Platform Market Share by Country (2021–2032)
Figure 27. United States Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Canada Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Europe Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Europe Generative Biology Intelligent Manufacturing Platform Market Share by Country (2021–2032)
Figure 31. Germany Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. France Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. U.K. Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Italy Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Russia Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Ireland Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Asia-Pacific Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Asia-Pacific Generative Biology Intelligent Manufacturing Platform Market Share by Region (2021–2032)
Figure 39. China Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Japan Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. South Korea Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Southeast Asia Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. India Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Australia & New Zealand Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Latin America Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Latin America Generative Biology Intelligent Manufacturing Platform Market Share by Country (2021–2032)
Figure 47. Mexico Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Brazil Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Middle East & Africa Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Middle East & Africa Generative Biology Intelligent Manufacturing Platform Market Share by Country (2021–2032)
Figure 51. Israel Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Saudi Arabia Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. UAE Generative Biology Intelligent Manufacturing Platform Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Ginkgo Bioworks Revenue Growth Rate in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
Figure 55. Absci Revenue Growth Rate in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
Figure 56. Amyris Revenue Growth Rate in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
Figure 57. Genomatica Revenue Growth Rate in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
Figure 58. Twist Bioscience Revenue Growth Rate in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
Figure 59. Inscripta Revenue Growth Rate in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
Figure 60. Synthego Revenue Growth Rate in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
Figure 61. Arzeda Revenue Growth Rate in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
Figure 62. Benchling Revenue Growth Rate in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
Figure 63. Insilico Medicine Revenue Growth Rate in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
Figure 64. Generate Biomedicines Revenue Growth Rate in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
Figure 65. Recursion Pharmaceuticals Revenue Growth Rate in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
Figure 66. Deep Genomics Revenue Growth Rate in Generative Biology Intelligent Manufacturing Platform Business (2021–2026)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Our Clients